Metastatic Type II Papillary Renal Cell Carcinoma With Recurrent Complete Responses to Sunitinib: A Case Report With a Literature Review

被引：1

作者：

Al Ashour, Bayan H. ^{[1
]}

Azam, Faisal ^{[2
]}

Ibnshamsah, Fahad ^{[2
,3
]}

Alrowais, Fahad ^{[4
]}

Al -Garni, Ayed ^{[5
]}

Al-Shamsi, Humaid O. ^{[6
,7
,8
]}

Bukhari, Nedal ^{[2
,3
]}

机构：

[1] Imam Abdulrahman Bin Faisal Univ, Coll Med, Dammam, Saudi Arabia

[2] King Fahad Specialist Hosp, Dept Med Oncol, Dammam, Saudi Arabia

[3] Imam Abdulrahman Bin Faisal Univ, Dept Internal Med, Dammam, Saudi Arabia

[4] King Fahad Specialist Hosp, Dept Radiat Oncol, Dammam, Saudi Arabia

[5] King Fahad Specialist Hosp, Dept Pathol & Lab Med, Dammam, Saudi Arabia

[6] Emirates Oncol Soc, Depatment Oncol, Dubai, U Arab Emirates

[7] Burjeel Canc Inst, Dept Oncol, Abu Dhabi, U Arab Emirates

[8] Univ Sharjah, Coll Med, Sharjah, U Arab Emirates

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2022年 / 14卷 / 05期

关键词：

complete response; sunitinib; tyrosine kinase inhibitors; papillary; renal cell carcinoma;

D O I：

10.7759/cureus.25541

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Papillary renal cell carcinoma (PRCC) is a less common subtype of kidney cancer and is typically more resistant to systemic treatments. This report describes a patient with metastatic type II PRCC who experienced two complete responses (CR) to the tyrosine kinase inhibitor (TKI) sunitinib. The patient remains on sunitinib with durable control of the disease. To the best of our knowledge, this is the first case of metastatic type II PRCC with CR to sunitinib.

引用

页数：5

共 50 条

[1] Partial remission of metastatic papillary thyroid carcinoma with sunitinib. Report of a case and review of the literature
Kaldrymides, Ph.
Kostoglou-Athanassiou, I.
Gkountouvas, A.
Veniou, E.
Ziras, N.
ENDOCRINE, 2010, 37 (01) : 6 - 10
[2] Partial remission of metastatic papillary thyroid carcinoma with sunitinib. Report of a case and review of the literature
Ph. Kaldrymides
I. Kostoglou-Athanassiou
A. Gkountouvas
E. Veniou
N. Ziras
Endocrine, 2010, 37 : 6 - 10
[3] Primary extrarenal papillary type II renal cell carcinoma presenting as a pelvic mass: a case report and review of the literature
Sarafi, Aikaterini
Tasis, Nikolaos
Mpalampou, Eleni
Igoumenidi, Maria
Arkoumani, Evdokia
Tzovaras, Alexandros
Korkolis, Dimitrios P.
Tsirlis, Theodoros
JOURNAL OF SURGICAL CASE REPORTS, 2024, 2024 (07):
[4] Complete remission of metastatic renal cell carcinoma to the bone with sunitinib
Yoshimura, Akihiro
Nakata, Wataru
Yamamichi, Gaku
Tsujimura, Go
Tsujimoto, Yuichi
Nin, Mikio
Tsujihata, Masao
UROLOGY CASE REPORTS, 2020, 32
[5] Sunitinib rechallenge with dose escalation in progressive metastatic renal cell carcinoma A case report and literature review
Zhang, Xingming
Shen, Pengfei
Yao, Jin
Chen, Ni
Liu, Jiyan
Zeng, Hao
MEDICINE, 2018, 97 (31)
[6] Cutaneous metastases of papillary renal cell carcinoma: A case report and review of the literature
Cardwell, Leah A.
Bender, Nicole R.
Sokumbi, Olayemi
JOURNAL OF CUTANEOUS PATHOLOGY, 2019, 46 (12) : 960 - 964
[7] Metastatic Renal Cell Carcinoma to the Scalp: A Case Report With Review of Literature
Meshikhes, Huda A.
Khatem, Raihanah S. Al
Albusaleh, Hassan M.
Alzahir, Ali A.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
[8] Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: a case report and review of the literature
Halit Karaca
Ayhan Lale
Mustafa Dikilitas
Metin Ozkan
Ozlem Er
Medical Oncology, 2010, 27 : 1023 - 1026
[9] Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: a case report and review of the literature
Karaca, Halit
Lale, Ayhan
Dikilitas, Mustafa
Ozkan, Metin
Er, Ozlem
MEDICAL ONCOLOGY, 2010, 27 (03) : 1023 - 1026
[10] Papillary renal cell carcinoma: what is missing in research? A case report and a review of literature
Eldessouki, Ihab
Gaber, Ola
Shehata, Mahmoud A.
Namad, Tariq
Atallah, Joseph
Masineni, Harsha
Karim, Nagla Abdel
SAGE OPEN MEDICAL CASE REPORTS, 2019, 7

← 1 2 3 4 5 →